Christie CounterAct products with patented Care222 technology are not for use as or for medical devices or for use on humans or animals or to disinfect medical devices.
This product is not intended to diagnose, treat, cure or prevent any disease.
Christie CounterAct products with patented Care222 technology and their pathogen reducing use in occupied spaces is dependent on proper installation and operational specifications, in accordance with American Conference of Governmental Industrial Hygienists (ACGIH) guidelines and IEC 62471.
Professional installation is recommended for Christie CounterAct products.
All references to “disinfect”, “disinfecting” and “disinfection” refer generally to the reduction of pathogenic bioburden and are not intended to refer to any specific definition as may be used by any governmental or regulatory authority including the U.S. Food and Drug Administration and the U.S. Environmental Protection Agency.
The Care222® standard character mark and stylized logo mark are registered trademarks of Ushio America, Inc. in the United States, Japan, European Union, and United Kingdom.